MiR-337–3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB-Reference-Cited by-同舟云学术

MiR-337–3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB

Published:2020-01 Issue: Volume:469 Page:54-67
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhang Zhen,Zhang Luoyan,Wang Bin,Wei Ran,Wang Yunxia,Wan Jipeng,Zhang Chi,Zhao Lin,Zhu Xiaoxiao,Zhang Yunhong,Chu Chu,Guo Qiang,Yin Xunqiang,Li Xia^ORCID

Funder

National Natural Science Foundation of China

Primary Research and Development Plan of Shandong Province

Project of Transformation in High-tech Achievements

Natural Science Foundation of Shandong Province

Taishan Scholars

Innovation Project of Shandong Academy of Medical Sciences

medical and health technology development program of Shandong province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference54 articles.

1. Cancer statistics;Jemal;CA A Cancer J. Clin.,2007

2. Ovarian cancer statistics;Torre;CA A Cancer J. Clin.,2018

3. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features;Prat;Virchows Arch.,2012

4. Epithelial ovarian cancer: evolution of management in the era of precision medicine;Lheureux;CA A Cancer J. Clin.,2019

5. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel;CA A Cancer J. Clin.,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect;Cellular Signalling;2024-08

2. Exosomes derived from mir-337-3p over-expressing tendon stem cells protect against apoptosis of tenocytes via targeting caspase3;BMC Musculoskeletal Disorders;2024-07-19

3. Genetic and epigenetic differentiation in response to genomic selection for avian lay date;Evolutionary Applications;2024-06-28

4. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28